78 related articles for article (PubMed ID: 2103236)
1. [Changes in phagocytosis of aerobic bacteria by neutrophils after exposure to subinhibitory concentrations of aztreonam and ciprofloxacin].
Gutiérrez Fernández J; Alados Arboledas JC; Castillo Pérez AM; Maroto Vela MC; Piedrola de Angulo G
An Med Interna; 1990 Feb; 7(2):63-6. PubMed ID: 2103236
[TBL] [Abstract][Full Text] [Related]
2. The influence of cefoperazone, cefotaxime, ceftazidime and aztreonam on phagocytosis by human neutrophils in vitro.
Lingaas E; Midtvedt T
J Antimicrob Chemother; 1989 May; 23(5):701-10. PubMed ID: 2668245
[TBL] [Abstract][Full Text] [Related]
3. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
4. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
Pruul H; Lewis G; McDonald PJ
J Antimicrob Chemother; 1988 Nov; 22(5):675-86. PubMed ID: 3209526
[TBL] [Abstract][Full Text] [Related]
5. Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.
Pascual A; Martínez-Martínez L; Perea EJ
Chemotherapy; 1989; 35(1):17-22. PubMed ID: 2721289
[TBL] [Abstract][Full Text] [Related]
6. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Veringa E; Box A; Rozenberg-Arska M; Verhoef J
Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
Klietmann W; Focht J; Nösner K
Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
[TBL] [Abstract][Full Text] [Related]
8. Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils.
Lingaas E; Midtvedt T
Drugs Exp Clin Res; 1985; 11(11):747-54. PubMed ID: 3915464
[TBL] [Abstract][Full Text] [Related]
9. Effect of ciprofloxacin on phagocytosis.
Forsgren A; Bergkvist PI
Eur J Clin Microbiol; 1985 Dec; 4(6):575-8. PubMed ID: 2936604
[TBL] [Abstract][Full Text] [Related]
10. How and why aztreonam works.
Rittenbury MS
Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ciprofloxacin on the phagocytosis of Escherichia coli by human polymorphonuclear leukocytes].
Pérez P; Herrera I; Martín M; Gómez-Lus ML; Prieto J
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):411-4. PubMed ID: 8260511
[TBL] [Abstract][Full Text] [Related]
12. Intraphagocytic killing of gram-positive bacteria by ciprofloxacin.
Pemán J; Cantón E; Hernández MT; Gobernado M
J Antimicrob Chemother; 1994 Dec; 34(6):965-74. PubMed ID: 7730239
[TBL] [Abstract][Full Text] [Related]
13. [Survey on drug resistance to ciprofloxacin in common pathogenic bacteria].
Zhang YL; Geng SN; Lai FC; Wang NP
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):378-9. PubMed ID: 12390755
[TBL] [Abstract][Full Text] [Related]
14. Effect of aztreonam upon human polymorphonuclear leukocyte functions.
Rodríguez AB; Sánchez C; Barriga C
Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):131-6. PubMed ID: 1563260
[TBL] [Abstract][Full Text] [Related]
15. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oxidative stress induced by ciprofloxacin and pyoverdin in bacteria and in leukocytes to evaluate toxicity.
Becerra MC; Eraso AJ; Albesa I
Luminescence; 2003; 18(6):334-40. PubMed ID: 14694423
[TBL] [Abstract][Full Text] [Related]
18. Interactions between antibiotics and human neutrophils in the killing of staphylococci.
Root RK; Isturiz R; Molavi A; Metcalf JA; Malech HL
J Clin Invest; 1981 Jan; 67(1):247-59. PubMed ID: 7451652
[TBL] [Abstract][Full Text] [Related]
19. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Keller N; Raponi G; Hoepelman IM; Overbeek BP; Rozenberg-Arska M; Verhoef J
Zentralbl Bakteriol; 1991 Jan; 274(4):519-26. PubMed ID: 1907453
[TBL] [Abstract][Full Text] [Related]
20. [The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Sener B; Hayran M; Kocagöz T; Ustaçelebi S
Mikrobiyol Bul; 1990 Apr; 24(2):120-5. PubMed ID: 2128529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
